Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03386838
Title An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck
Recruitment Withdrawn
Gender both
Phase Phase III
Variant Requirements No
Sponsors Bristol-Myers Squibb

oral squamous cell carcinoma

hypopharynx cancer

laryngeal squamous cell carcinoma

head and neck squamous cell carcinoma

oropharynx cancer


BMS-986205 + Nivolumab

Carboplatin + Cetuximab + Cisplatin + Fluorouracil

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.